The effect of insulin infusion on heart rate and systemic blood pressure in horses with equine metabolic syndrome - PubMed (original) (raw)

. 2019 Nov;51(6):733-737.

doi: 10.1111/evj.13110. Epub 2019 Apr 5.

Affiliations

• PMID: 30887546
• DOI: 10.1111/evj.13110

The effect of insulin infusion on heart rate and systemic blood pressure in horses with equine metabolic syndrome

K Nostell et al. Equine Vet J. 2019 Nov.

Abstract

Background: There is little evidence that horses with equine metabolic syndrome (EMS) have higher resting blood pressures than horses with normal insulin sensitivity. However, there are indications that EMS horses have an altered dynamic response to the cardiovascular effects of insulin.

Objectives: To examine heart rate and the systemic blood pressure response in EMS and control horses during insulin infusion.

Study design: Cross-sectional study.

Methods: Horses were examined with an oral sugar test (OST) and a euglycaemic hyperinsulinaemic clamp (EHC). Based on the results from the OST, the horses were classified as either EMS or control. Blood pressure was measured before the start of the EHC and at 60, 120 and 180 min of the EHC.

Results: There were 16 EMS and 12 control horses. Mean resting heart rate was higher for EMS horses compared with control (35.6 ± 5.1 vs. 30.3 ± 3.5 beats/min). Systolic, diastolic and mean arterial blood pressure did not differ between groups at the start of the EHC. Blood pressure decreased gradually during the EHC in the control group, whereas the EMS group showed no decline in systolic, diastolic or mean arterial pressure.

Main limitations: Limited number of horses.

Conclusions: Horses with EMS have cardiovascular changes that affect resting heart rate and systemic blood pressure during insulin infusion.

Keywords: EHC; cardiovascular; horse; insulin.

© 2019 EVJ Ltd.

PubMed Disclaimer

Similar articles

• Blood pressure in Warmblood horses before and during a euglycemic-hyperinsulinemic clamp.
  Nostell KE, Lindåse SS, Bröjer JT. Nostell KE, et al. Acta Vet Scand. 2016 Oct 20;58(Suppl 1):65. doi: 10.1186/s13028-016-0247-y. Acta Vet Scand. 2016. PMID: 27766986 Free PMC article.
• Metabolic and inflammatory responses to the common sweetener stevioside and a glycemic challenge in horses with equine metabolic syndrome.
  Elzinga SE, Rohleder B, Schanbacher B, McQuerry K, Barker VD, Adams AA. Elzinga SE, et al. Domest Anim Endocrinol. 2017 Jul;60:1-8. doi: 10.1016/j.domaniend.2017.01.001. Epub 2017 Feb 4. Domest Anim Endocrinol. 2017. PMID: 28254632
• Heritability of metabolic traits associated with equine metabolic syndrome in Welsh ponies and Morgan horses.
  Norton EM, Schultz NE, Rendahl AK, Mcfarlane D, Geor RJ, Mickelson JR, McCue ME. Norton EM, et al. Equine Vet J. 2019 Jul;51(4):475-480. doi: 10.1111/evj.13053. Epub 2018 Dec 15. Equine Vet J. 2019. PMID: 30472742
• Diabetes, insulin resistance, and metabolic syndrome in horses.
  Johnson PJ, Wiedmeyer CE, LaCarrubba A, Ganjam VK, Messer NT 4th. Johnson PJ, et al. J Diabetes Sci Technol. 2012 May 1;6(3):534-40. doi: 10.1177/193229681200600307. J Diabetes Sci Technol. 2012. PMID: 22768883 Free PMC article. Review.
• The equine metabolic syndrome peripheral Cushing's syndrome.
  Johnson PJ. Johnson PJ. Vet Clin North Am Equine Pract. 2002 Aug;18(2):271-93. doi: 10.1016/s0749-0739(02)00006-8. Vet Clin North Am Equine Pract. 2002. PMID: 15635908 Review.

Cited by

• Short-term effects of canagliflozin on glucose and insulin responses in insulin dysregulated horses: A randomized, placebo-controlled, double-blind, study.
  Lindåse S, Nostell K, Forslund A, Bergsten P, Bröjer J. Lindåse S, et al. J Vet Intern Med. 2023 Nov-Dec;37(6):2520-2528. doi: 10.1111/jvim.16906. Epub 2023 Oct 21. J Vet Intern Med. 2023. PMID: 37864426 Free PMC article.
• Effect of a long-term high-energy diet on cardiovascular parameters in Shetland pony mares.
  D' Fonseca NMM, Beukers M, Wijnberg ID, Navas de Solis C, de Ruijter-Villani M, van Doorn DA, Stout TAE, Roelfsema E. D' Fonseca NMM, et al. J Vet Intern Med. 2021 Sep;35(5):2427-2436. doi: 10.1111/jvim.16229. Epub 2021 Aug 5. J Vet Intern Med. 2021. PMID: 34350640 Free PMC article.
• Evaluation of fasting plasma insulin and proxy measurements to assess insulin sensitivity in horses.
  Lindåse S, Nostell K, Bergsten P, Forslund A, Bröjer J. Lindåse S, et al. BMC Vet Res. 2021 Feb 15;17(1):78. doi: 10.1186/s12917-021-02781-5. BMC Vet Res. 2021. PMID: 33588833 Free PMC article.
• Role of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited.
  da Silva AA, do Carmo JM, Li X, Wang Z, Mouton AJ, Hall JE. da Silva AA, et al. Can J Cardiol. 2020 May;36(5):671-682. doi: 10.1016/j.cjca.2020.02.066. Epub 2020 Feb 12. Can J Cardiol. 2020. PMID: 32389340 Free PMC article. Review.

References

1. 1. Morgan, R.A., Keen, J.A., Walker, B.R. and Hadoke, P.W. (2016) Vascular dysfunction in horses with endocrinopathic laminitis. PLoS One 11, e0163815. https://doi.org/10.1371/journal.pone.0163815.
2. 1. Heliczer, N., Gerber, V., Bruckmaier, R., van der Kolk, J.H. and Navas de Solis, C. (2017) Cardiovascular findings in ponies with equine metabolic syndrome. J. Am. Vet. Med. Ass. 250, 1027-1035.
3. 1. Zeng, G. and Quon, M.J. (1996) Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J. Clin. Invest. 98, 894-898.
4. 1. Zeng, G., Nystrom, F.H., Ravichandran, L.V., Cong, L.N., Kirby, M., Mostowski, H. and Quon, M.J. (2000) Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation 101, 1539-1545.
5. 1. Muniyappa, R., Montagnani, M., Kon Koh, K. and Quon, M.J. (2007) Cardiovascular actions of insulin. Endocr. Rev. 28, 463-491.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wiley

• Medical

  • MedlinePlus Health Information